...Alessandro Cattoni; Enrico Clarke; Assunta Albanese Background: The literature contains conflicting reports on the value of low insulin-like growth factor 1 (IGF-1) levels in predicting radiation-induced growth hormone (GH) deficiency (GHD) in childhood cancer survivors (CCS). These reports often...

...Madhusmita Misra; Anne Klibanski Anorexia nervosa (AN) is a condition of severe undernutrition associated with adaptive changes in many endocrine axes. These changes include hypogonadotropic hypogonadism, acquired growth hormone resistance with low insulin-like growth factor 1 (IGF-1) levels...

...Sheau Chui Ho; Peter Clayton; Pradeep Vasudevan; James Greening; Barbara Wardhaugh; Nick Shaw; Christopher Kelnar; Jeremy Kirk; Wolfgang Högler Background: The insulin-like growth factor 1 receptor (IGF IR) gene is located on chromosome 15q26.3. Heterozygous 15q26 deletions involving the IGFIR gene...

... for their age and height. Aim: To verify whether leptin, insulin-like growth factor 1 (IGF-1) or another hormonal marker could be a good predictor of the return of menses. Patients and Methods: This prospective study included female adolescents diagnosed with AN or eating disorders not otherwise specified...

...Mohamed El Kholy; Nermine Hussein Amr; Heba Elsedfy Background/Aim: Growth hormone insensitivity syndrome (GHIS) is a spectrum of disorders. Laron syndrome was the earliest discovered. Insulin-like growth factor 1 (IGF-1) therapy is used to improve growth. IGF-1 has diverse effects on the growth...

... had higher diastolic BP. Possible inflammatory markers of cardiovascular disease were not different [ 19 ]. Insulin-like growth factor 1 Insulin-like growth factor-binding protein 3 Truncal fat Systolic blood pressure Ethnicity Mechanisms for translating early programming into later...

... hormone Insulin-like growth factor 1 Insulin-like growth factor-binding protein 3 Small for gestational age 24 06 2011 25 10 2011 8 12 2011 © 2011 S. Karger AG, Basel 2011 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

... GH1 LCR/promoter SNPs to height, serum insulin-like growth factor 1 (IGF-I) levels and response to GH treatment. Results: In IGHD patients, promoter SNPs 6, 8 and 9 were associated with height and IGF-1 levels. In controls, SNPs 6 and 11 were associated with height. Homozygosity for the minor allele...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. C-peptide Insulin sensitivity Insulin-like growth factor 1 Muscle mass Fat mass...

...Hideaki Saito; Tomomi Inoue; Kazuhiko Fukatsu; Lin Ming-Tsan; Tuyoshi Inaba; Ryoji Fukushima; Tetsuichiro Muto Growth hormone (GH) and insulin-like growth factor 1 (IGF-1), especially the former, have immunoregulatory effects in addition to anabolic effects. The hormones may act to protect the host...

...Yaacov Baruch; Tamar Amit; Pnina Hertz; Rafael Enat; Gideon Shoshany; Moussa B.H. Youdim; Zeev Hochberg The role of the liver in regulating serum growth hormone-binding protein (GH-BP) was studied. We measured rat serum GH-BP and insulin-like growth factor 1 (IGF-1) 30 min to 96 h after 70% partial...

... Growth hormone Insulin-like growth factor 1 Thyrotropin-releasing hormone test Luteinizing hormone-releasing hormone test Somatostatin Acromegaly Evaluation of GH Paradoxical Responses to TRH and LHRH in Acromegalic Patients during Long-T erm T reatment with Octreotide Abstract In some acromegalics. GH...

... effects of GH, and (b) that skeletal muscle force may be reduced due to altered muscle mass, contractile elements/muscle fibre, anaerobic energy supply, neural recruitment of fibres, or a combination of these. Insulin-like growth factor 1 Lean body mass Skeletal muscle Somatotropin Strength ©...

... acromegaly developed. Complete GH deficiency had been diagnosed earlier by arginine stimulation testing, and therapy with recombinant human GH (maintenance dose 2 IU/day) was implemented at the age of 54 years. At presentation, the patient’s insulin-like growth factor 1 (IGF-1; 439 ng/ml) and insulin-like...

... at this evaluation. The plasma insulin-like growth factor 1 was initially below –2 z-score in 12/13 of these patients and similarly low in 4/17 patients at the third evaluation. The growth rates of the three groups before and their increase during the 1st year of treatment were similar. Conclusion: Almost all...